The number of sprays per nostril and frequency of administration may vary, necessitating adherence to the specific guidelines
Cell 16 , 849860 (2005)
Together, these findings and the wide range of effectiveness of the BPC 157 regimens (pg, ng, g, eye drops, or systemically, including via per-oral route) (for review see [1,2,3,4,5,6,7,8,9,10,96,97,106,107,193]) may be suggestive of further BPC 157 therapy application
10.1016/j.mce.2008.11.015 112 VangaS
One study employed chitosan nanoparticles as carriers for both the chemotherapy compound and AOD 9604 peptide, hypothesizing that AOD 9604 may potentially facilitate the binding of the compound to multiple protein targets within breast cancer cells, thereby augmenting its anti-proliferative effects